Drug Development

Articles

The project will focus on providing a faster route to clinical studies for AstraZeneca’s potential COVID-19 vaccine, AZD1222.

AstraZeneca and IQVIA Partner on Potential COVID-19 Vaccine

The UK government has secured early access to 90 million COVID-19 vaccine doses from the BioNTech/Pfizer alliance and Valneva.

UK Government Secures Early Access to Millions of COVID-19 Vaccine Doses

Study reports immune and T-cell response from CanSino COVID-19 vaccine candidate. 

CanSino Vaccine Produces Immune Response

Preliminary data from a German Phase I/II trial shows Pfizer/BioNTech COVID-19 vaccine candidate produces immune response.

mRNA Vaccine Produces Immune and T-cell Response

Strong immune response by patients receiving two doses of vaccine suggests a possible treatment strategy.

AstraZeneca Vaccine Shows Antibody and T-cell responses

Global regulatory authorities have published a report describing the aligned positions on COVID-19 vaccine development, which were agreed upon by meeting participants of the second workshop on COVID-19 vaccine development.

Regulatory Authorities have Published a Report on COVID Vaccine Development

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA officials are moving to clarify standards and requirements for vetting and approving viable preventives. 

FDA Maps Expectations for COVID Vaccine Proposals

VAR2 Pharmaceuticals has been selected for its development of a drug-conjugated malaria protein that potentially selectively binds to most human tumor types.


VAR2 Pharmaceuticals Wins MilliporeSigma’s Advance Biotech Grant

BARDA and DOD have awarded a $450-million contract to Regeneron Pharmaceuticals to manufacture and supply an investigational double antibody cocktail in development for treating COVID-19.

BARDA, DOD Award $450-Million COVID-19 Manufacturing and Supply Contract to Regeneron

The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union.

Formulation and Drug Delivery